NEW YORK, Feb. 11 (GenomeWeb News) - Affymetrix and the Translational Genomics Research Institute of Phoenix, Ariz., today announced a non-exclusive agreement where TGEN genotyping services to its collaborators and NIH-funded core facility programs using Affymetrix's DNA analysis technology.
TGen currently runs gene expression core facility programs on the Affymetrix platform for The National Institutes of Mental Health and the National Institutes of Neurological Disease and Stroke. As part of this agreement, these programs have been expanded to run the Affymetrix DNA analysis technologies. Affymetrix and TGen also agreed to a framework under which they will collaborate on future projects.
Financial details of the agreement were not disclosed.